Second Quarter 2026
Filed Aug 11, 2026Continued Momentum – Q2 total revenue UP 13%; Sustained Growth - Six-month total revenue UP 14%
Second-quarter revenue grew 12.9%, led by procurement revenue growth of 64.0%, but operating loss, net loss and adjusted EBITDA loss widened from the prior-year quarter amid supply-chain constraints and higher component and freight costs.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total revenues, three months ended June 30, 2026GAAP | $ 6,462,542 | – | 12.9 % |
| Loss from operations, three months ended June 30, 2026GAAP | $ (1,512,371 ) | – | 33.8 % |
| Net loss, three months ended June 30, 2026GAAP | $ (1,351,498 ) | – | 28.7 % |
| Net cash (used in) operating activities, three months ended June 30, 2026other | $ (591,018 ) | – | (33.5 )% |
| Adjusted EBITDA, three months ended June 30, 2026non-GAAP | $ (610,254 ) | – | 61.3 % |
| Total revenues, six months ended June 30, 2026GAAP | $ 12,817,293 | – | 14.0 % |
| Loss from operations, six months ended June 30, 2026GAAP | $ (2,280,553 ) | – | (74.3 )% |
| Net (loss) income, six months ended June 30, 2026GAAP | $ (2,011,712 ) | – | (733.0 )% |
| Net cash (used in) provided by operating activities, six months ended June 30, 2026other | $ (786,730 ) | – | (191.9 )% |
| Adjusted EBITDA, six months ended June 30, 2026non-GAAP | $ (777,773 ) | – | (9.6 )% |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Managed information technology revenueIncreased managed information technology revenue was attributed to new customers and expansion of services sold to existing customers. | $3.8 million | – | 8.4% |
| Procurement revenueIncrease related to sales of AI-related equipment to customers. | $2.0 million | – | 64.0% |
| Professional services revenueThe release reported a decrease in professional services revenue. | $363,055 | – | a decrease of 47.3% |
| Subscription revenueRevenue from NewtekOne, Inc., a related party, was impacted by its ongoing initiatives to reduce information technology spending. | $249,490 | – | a decrease of 10.5% |
Capital returns
- Repurchased 50,000 shares of common stock during the first quarter of 2026, under our stock repurchase plan for an aggregate of $83,491.
- As of June 30, 2026, all shares of common stock available for repurchase under the stock repurchase plan had been repurchased and such plan had expired.
What drove it
- Total revenue growth was driven by increased managed information technology revenue from new customers and expansion of services to existing customers, plus higher procurement revenue related to AI-related equipment.
- Procurement revenue increased as customers focused on building out infrastructure to execute on their AI initiatives.
- IPM added new customer relationships and service contracts and expanded its sales organization with a dedicated territory focused on the Phoenix metropolitan area and broader West Coast market.
- The Company extended its Phoenix data center colocation license agreement through August 2032, entered a strategic collaboration with MASORI Therapeutics, and achieved SOC 2 Type 1 compliance.
Concerns
- Supply-chain constraints affecting memory, CPU and GPU availability extended product lead times and delayed the interval between customer bookings and product shipments.
- A portion of booked orders remained unrecognized as of June 30, 2026 pending fulfillment and delivery.
- The second shipment of a significant customer order incurred higher component and freight costs, resulting in a loss on that portion; the combined order resulted in a loss and contributed to increased cost of revenue.
- Professional services revenue decreased 47.3% and subscription revenue decreased 10.5% from Q2 2025.
- Revenue from NewtekOne, Inc. was impacted by its initiatives to reduce information technology spending.
- Second-quarter loss from operations, net loss and adjusted EBITDA loss were larger than in the prior-year quarter.
What to watch
- Recognition in future quarters of booked orders pending fulfillment and delivery.
- Management's addition of distributors, vendors, partners and manufacturers to diversify procurement sources.
- Whether higher component and freight costs continue to affect cost of revenue on procurement orders.
- Growth in recurring revenue from non-related-party customers and the effect of reduced information technology spending by NewtekOne, Inc.
- Execution of the MASORI Therapeutics collaboration and the expanded Phoenix and West Coast sales coverage.
Balance sheet and cash flow
- Deferred revenue was $4.5 million as of June 30, 2026, which will be recognized as revenue in future quarters as products and/or services are installed.
- At June 30, 2026 we had $7.5 million of cash and cash equivalents on our balance sheet and no long-term debt.
- Cash used in operations totaled $0.6 million for the three months ended June 30, 2026 compared to cash used in operations of $0.9 million for the three months ended June 30, 2025, primarily related to our sourcing of product in connection with the increased procurement revenue.
- Cash used by operations of $0.8 million for the six months ended June 30, 2026 compared to cash provided by operations of $0.9 million for the six months ended June 30, 2025, primarily related to our sourcing of inventory in connection with the increased procurement revenue.
Analysis
IPM reported second-quarter total revenues of $ 6,462,542, up 12.9 % from $ 5,722,599 in the prior-year quarter. Growth came from managed information technology revenue of $3.8 million, up 8.4%, and procurement revenue of $2.0 million, up 64.0%. Management attributed the procurement increase to AI-related equipment purchases as customers built infrastructure for AI initiatives. Professional services revenue of $363,055 and subscription revenue of $249,490 declined from Q2 2025, while NewtekOne, Inc. reduced information technology spending.
The revenue mix produced weaker reported profitability in the quarter. Loss from operations was $ (1,512,371), compared with $ (1,129,699), while net loss was $ (1,351,498), compared with $ (1,050,028). Adjusted EBITDA, a non-GAAP measure, was $ (610,254), compared with $ (378,289). Management said a significant customer order was fulfilled across two reporting periods because of supply constraints; its second-quarter shipment incurred higher component and freight costs and recorded a loss, causing the combined order to result in a loss and contributing to higher cost of revenue.
Supply-chain constraints in memory, CPU and GPU components delayed product availability, customer shipments and revenue recognition. IPM stated that some booked orders remained unrecognized as of June 30, 2026, pending fulfillment and delivery in future quarters. Deferred revenue was $4.5 million as of June 30, 2026. Management is adding distributors, vendors, partners and manufacturers to diversify its sourcing base. These fulfillment conditions and the timing of recognizing the pending orders are central operating items to follow.
Cash used in operating activities was $ (591,018) in the quarter, compared with $ (888,678) in the prior-year quarter, with management citing sourcing of product connected to increased procurement revenue. For the six months, net cash used in operating activities was $ (786,730), compared with net cash provided by operating activities of $ 856,105 in the prior-year period. IPM ended June 30, 2026 with $7.5 million of cash and cash equivalents and no long-term debt. It also repurchased 50,000 shares for an aggregate of $83,491 during the first quarter, and the repurchase plan had expired by June 30, 2026.
For the first six months, total revenues were $ 12,817,293, up 14.0 %, while the operating loss improved to $ (2,280,553) from $ (2,463,626). However, net loss was $ (2,011,712) versus $ (241,498), and operating cash flow turned negative. The filing does not provide a prior-quarter comparison or forward financial guidance. Operationally, IPM highlighted new customer relationships and service contracts, a Phoenix and West Coast sales expansion, a Phoenix data center agreement through August 2032, SOC 2 Type 1 compliance, and a collaboration with MASORI Therapeutics.
Management, verbatim
Financial results for the second quarter of 2026 were solid despite supply chain constraints, achieving a 13% increase in total revenue to $6.5 million compared to last year’s second quarter.
Jason Katz, Chairman and Chief Executive Officer
We experienced supply chain constraints during the quarter, which affected the availability of memory, CPU and GPU components throughout the quarter.
Jason Katz, Chairman and Chief Executive Officer
With a strong balance sheet, no long-term debt and a growing pipeline, we believe we are well positioned to move aggressively and integrate operations that are synergistic with our core operations and can be acquired at reasonable valuations to provide greater returns for our loyal stockholders.
Jason Katz, Chairman and Chief Executive Officer
Not in the filing
stated, not guessed- GAAP diluted EPS
- non-GAAP diluted EPS
- gross profit
- gross margin
- operating expenses
- tax rate
- free cash flow
- dividend amount or dividend declaration
- total debt other than the statement of no long-term debt
- prior-quarter comparisons for reported metrics
- forward financial guidance
- prior outlook for comparison with reported results
- six-month revenue amounts by managed information technology, procurement, professional services and subscription revenue components
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.